Parkinson’s disease (PD) is characterized by the activation of degenerative and inflammatory processes in brain circuits that control movement and, according to the degree of progression of the damage, can cause neuropsychological disorders such as cognitive dysfunction. Changes in gene expression profile or post-translational modifications in secretory proteins such as neurotrophic factors could define the disease progression. Brain-derived neurotrophic factor (BDNF) is relevant, because it not only participates in neuronal survival, neurotransmission, dendritic growth and cellular communication but also in disease progression. In this chapter, considering both experimental evidences and clinical reports, the authors will analyze the contr...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with an incidence of ...
Neuroinflammation is one of the most important processes involved in the pathogenesis of Parkinson's...
Parkinson’s disease (PD) is a neurodegenerative disease that affects 6.1 million people globally as ...
Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are essential for neuronal survival...
Parkinson's disease (PD) is a chronic, neurodegenerative disease with a 1% incidence in the populat...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Parkinson's disease (PD is a progressive neurological disorder characterized by the degeneration and...
Parkinson’s Disease (PD) is a highly prevalent neurodegenerative disease that affects millions of pe...
Globally, neurodegenerative diseases cause a significant degree of disability and distress. Brain-de...
© Springer International Publishing Switzerland 2014Parkinson's disease (PD) is a chronic movement d...
Background Neurotrophic factors are endogenous proteins promoting the survival of different neural c...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Brain-derived neurotrophic factor (BDNF) is a small dimeric protein, structurally related to nerve g...
Perhaps the most important unmet clinical need in Parkinson's disease (PD) is the development of a t...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with an incidence of ...
Neuroinflammation is one of the most important processes involved in the pathogenesis of Parkinson's...
Parkinson’s disease (PD) is a neurodegenerative disease that affects 6.1 million people globally as ...
Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are essential for neuronal survival...
Parkinson's disease (PD) is a chronic, neurodegenerative disease with a 1% incidence in the populat...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Parkinson's disease (PD is a progressive neurological disorder characterized by the degeneration and...
Parkinson’s Disease (PD) is a highly prevalent neurodegenerative disease that affects millions of pe...
Globally, neurodegenerative diseases cause a significant degree of disability and distress. Brain-de...
© Springer International Publishing Switzerland 2014Parkinson's disease (PD) is a chronic movement d...
Background Neurotrophic factors are endogenous proteins promoting the survival of different neural c...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Brain-derived neurotrophic factor (BDNF) is a small dimeric protein, structurally related to nerve g...
Perhaps the most important unmet clinical need in Parkinson's disease (PD) is the development of a t...
The concept of repairing the brain with growth factors has been pursued for many years in a variety ...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, with an incidence of ...
Neuroinflammation is one of the most important processes involved in the pathogenesis of Parkinson's...
Parkinson’s disease (PD) is a neurodegenerative disease that affects 6.1 million people globally as ...